Company intelligence / Profile preview

Applied Lipid Therapeutics

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Applied Lipid Therapeutics is a biotechnology company focused on developing novel small molecule inhibitors for the treatment of metabolic and inflammatory diseases. The company's primary focus is on targeting aldose reductase, an enzyme involved in the polyol pathway that contributes to the development of diabetic complications. By inhibiting this enzyme, Applied Lipid Therapeutics aims to prevent or treat conditions such as diabetic cardiomyopathy, retinopathy, and nephropathy. The company is also exploring the potential of its lead candidates in rare metabolic disorders like galactosemia.

Therapeutic areas: CardiovascularMetabolic DisordersNephrologyOphthalmology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

epatg

Unknown

Beyond the preview

Go deeper on Applied Lipid Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied Lipid Therapeutics.

Explore the full profile